EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Placenta in Gestational Diabetes: An Integrated Review on Metabolic Pathways, Genetic, Epigenetic and Ultrasound Biomarkers for Clinical Perspectives

Giovanni Tossetta iD, Roberto Campagna iD, Arianna Vignini iD, Giuseppe Maria Maruotti, Mariarosaria Motta iD, Chiara Murolo, Laura Sarno iD, Camilla Grelloni iD, Monia Cecati, Stefano Raffaele Giannubilo iD, Andrea Ciavattini iD

International Journal of Molecular Sciences · 16.01.2026 · 27 (2) · 919

DOI: 10.3390/ijms27020919 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.01.2026. Verfasst von Giovanni Tossetta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Via di Val Cannuta, 247, 00166 Rome, Italy. Hauptthemen laut MEDLINE: Diabetes, Gestational, Biomarkers, Epigenesis, Genetic, Placenta. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnancies complicated by diabetes, including pregestational and gestational diabetes mellitus, are associated with increased maternal and fetal morbidity. Early identification of at-risk pregnancies is crucial for timely intervention and improved outcomes. Emerging evidence highlights the interplay of genetic predisposition, epigenetic modifications, and non-invasive biomarkers in the early detection of diabetic pregnancies. Genetic factors influencing insulin signaling, glucose metabolism, and pancreatic β-cell function may contribute to susceptibility to gestational hyperglycemia. Concurrently, epigenetic alterations, such as DNA methylation and histone modifications in maternal and placental tissues, have been linked to dysregulated metabolic pathways and adverse pregnancy outcomes. Non-invasive biomarkers, including circulating cell-free DNA and microRNAs in maternal blood, show promise for early diagnosis by offering a safer and more practical alternative to invasive testing. Integrating genetic, epigenetic, and molecular marker data could enhance risk stratification and enable personalized monitoring and management strategies. This review synthesizes current knowledge on the molecular underpinnings of diabetic pregnancies, evaluates the potential of emerging biomarkers for early diagnosis, and discusses the challenges and future perspectives for translating these findings into clinical practice. Understanding these mechanisms may pave the way for precision medicine approaches, ultimately improving maternal and neonatal outcomes in pregnancies affected by diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalBiomarkersEpigenesis, GeneticPlacentaMetabolic Networks and PathwaysHumansPregnancyFemaleDNA Methylation

Stichwörter der Autor:innen

dysregulated metabolic pathwaysepigenetic modificationsgenetic factorsgestational diabetes mellitusserum biomarkerssonographic markers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Via di Val Cannuta, 247, 00166 Rome, Italy.
  • Department of Clinical Sciences, Section of Biochemistry, Biology and Physics, Università Politecnica Delle Marche, 60126 Ancona, Italy.
  • Gynecology and Obstetrics Unit, Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
  • Department of Clinical Sciences, Clinic of Obstetrics and Gynaecology, Università Politecnica Delle Marche, 60123 Ancona, Italy.

ORCID-Profile: Giovanni Tossetta, Roberto Campagna, Arianna Vignini, Mariarosaria Motta, Laura Sarno, Camilla Grelloni, Stefano Raffaele Giannubilo, Andrea Ciavattini

Zitieren

APA

Tossetta, G., Campagna, R., Vignini, A., Maruotti, G. M., Motta, M., Murolo, C., Sarno, L., Grelloni, C., Cecati, M., Giannubilo, S. R., & Ciavattini, A. (2026). The Placenta in Gestational Diabetes: An Integrated Review on Metabolic Pathways, Genetic, Epigenetic and Ultrasound Biomarkers for Clinical Perspectives. International Journal of Molecular Sciences, 27(2), 919. https://doi.org/10.3390/ijms27020919

Vancouver

Tossetta G, Campagna R, Vignini A, Maruotti GM, Motta M, Murolo C, et al. The Placenta in Gestational Diabetes: An Integrated Review on Metabolic Pathways, Genetic, Epigenetic and Ultrasound Biomarkers for Clinical Perspectives. International Journal of Molecular Sciences. 2026;27(2):919. doi:10.3390/ijms27020919

BibTeX
@article{Tossetta2026,
  author = {Tossetta, Giovanni and Campagna, Roberto and Vignini, Arianna and Maruotti, Giuseppe Maria and Motta, Mariarosaria and Murolo, Chiara and Sarno, Laura and Grelloni, Camilla and Cecati, Monia and Giannubilo, Stefano Raffaele and Ciavattini, Andrea},
  title = {The Placenta in Gestational Diabetes: An Integrated Review on Metabolic Pathways, Genetic, Epigenetic and Ultrasound Biomarkers for Clinical Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {919},
  doi = {10.3390/ijms27020919}
}
Kostenlos starten →